Epitope spreading
Epitope spreading is a phenomenon observed in the immune response where the antibody response and/or T cell response changes over time to target different epitopes of the same antigen. This process can occur in both autoimmune diseases and infections, and is thought to contribute to the progression and diversification of the immune response.
Overview[edit | edit source]
Epitope spreading occurs when the immune response initially targets a specific epitope, but then begins to target additional epitopes on the same antigen. This can occur as a result of molecular mimicry, where the immune system mistakenly recognizes self-antigens as foreign due to their similarity to pathogenic antigens. It can also occur as a result of antigen processing and presentation, where different epitopes of the same antigen are presented to the immune system at different times.
Mechanisms[edit | edit source]
The mechanisms underlying epitope spreading are not fully understood, but several factors are thought to contribute. These include the release of cryptic epitopes, which are normally hidden from the immune system but can be exposed during the process of antigen processing and presentation. Additionally, the cross-reactivity of antibodies and T cells, which allows them to recognize and respond to multiple epitopes, may also play a role.
Clinical significance[edit | edit source]
Epitope spreading has been implicated in the progression of several autoimmune diseases, including multiple sclerosis, rheumatoid arthritis, and type 1 diabetes. In these diseases, the immune response initially targets a specific epitope, but then begins to target additional epitopes, leading to a broadening of the immune response and increased tissue damage.
In the context of infections, epitope spreading can contribute to the diversification of the immune response, potentially enhancing the ability of the immune system to control the infection. However, it can also lead to the development of immune escape variants, where the pathogen evolves to change its epitopes and evade the immune response.
See also[edit | edit source]
 | This immunology article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
